The monkeypox epidemic in Sierra Leone has raised significant public health concerns, prompting swift actions from regulatory bodies like the Pharmacy Board of Sierra Leone. Despite the demand for prompt treatment, the Board emphasizes that medical care for monkeypox symptoms must be sought exclusively at government-designated health facilities. This policy is critical to ensure proper diagnosis, treatment, and containment of the disease within controlled healthcare environments that are equipped to manage infectious diseases safely. Monkeypox, a zoonotic viral disease, shares symptoms similar to other poxviruses such as smallpox, including fever, rash, and swollen lymph nodes. The disease can spread through close contact and contaminated materials, making regulated medical management crucial. The Board's advisory aims to prevent unauthorized pharmaceutical intervention, which may result in improper treatment, further spread of infection, or adverse effects. The Pharmacy Board’s reminder that treating monkeypox in pharmaceutical outlets contravenes the Pharmacy and Drugs Act 2001 also underscores the importance of legal compliance in health service delivery. Violators face stringent legal repercussions, reflecting the government's dedication to enforcing laws that protect public safety. Additionally, the collaborative approach involving the Pharmacy Board, the Pharmaceutical Society of Sierra Leone, and the Pharmaceutical Business Association reflects a united front in guiding the public and pharmacy professionals. This tripartite coordination enhances awareness and compliance, helping mitigate the epidemic's impact. Public health education is paramount during outbreaks like monkeypox. People exhibiting symptoms such as fever, body aches, and rash consistent with monkeypox should promptly visit official health centers rather than pharmacies. These centers can provide laboratory testing, isolation measures, and appropriate antiviral treatments or supportive care as needed. In conclusion, the Pharmacy Board of Sierra Leone's continued commitment to public health safeguards through regulation enforcement and public advisories is vital. By channeling monkeypox-related medical attention to government-approved facilities, Sierra Leone can strengthen its epidemic control efforts, reduce illegal pharmaceutical practices, and ultimately protect the health and safety of its population.